Latest

visual hallucinations

·November 7, 2025·9 min read

New Therapy Reshapes Images That Fuel Psychosis

A new imagery-focused therapy called iMAPS may help people with psychosis gain control over disturbing mental images that fuel paranoia, fear, and hallucinations. In a feasibility trial of 45 participants, the approach showed strong patient engagement and meaningful reductions in distress by teaching individuals to understand, transform, and re-script intrusive images.

Featured Neuroscience Psychology Visual Neuroscience

·February 15, 2021·4 min read

Visual Hallucinations Among Blind People Increase During Pandemic

Loneliness, stress, and social isolation as a result of COVID-19 exacerbated and intensified visual hallucinations in blind people with Charles Bonnet Syndrome by 56%.

Featured Neurology Neuroscience Pain

·October 21, 2019·2 min read

One in three pain patients suffer side effects after ketamine infusion therapy

35% of patients who used ketamine to manage pain reported significant side effects ranging from hallucination, out-of-body experiences, visual disturbances, and urinary dysfunction. 20% of the side effects were linked directly to ketamine, and 15% associated with ketamine in combination with other drugs.

Featured Neurology Psychology

·September 27, 2017·4 min read

Brain Disconnections May Contribute to Parkinson’s Hallucinations

Researchers have identified functional connectivity problems in brain regions associated with visual processing and attention in Parkinson's patients who experience visual hallucinations.

Featured Psychology

·March 29, 2017·5 min read

Vulnerability to Psychosis: How to Detect it

Researchers have identified an early vulnerability biomarker for psychosis.

Featured Neurology Neuroscience Videos Open Neuroscience Articles Psychology

·October 12, 2016·6 min read

Did You See That? Inducing Visual Hallucinations in Healthy People

Researchers have developed a new method to induce visual hallucinations in healthy people. The study could help to develop new treatments to control hallucinations in people with Parkinson's and other disorders.